SCHEMBL29490474

SCHEMBL29490474

CN1CCC(n2cc(Nc3ncc(Cl)c(NCCCN4CCOCCC4=O)n3)cn2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ULK1 O75385 1/20 0.52
ULK2 Q8IYT8 1/20 0.52
JAK3 P52333 8/20 0.49
JAK1 P23458 6/20 0.49
JAK2 O60674 5/20 0.49
TBK1 Q9UHD2 5/20 0.48
FLT4 P35916 2/20 0.47
KDR P35968 2/20 0.47
TNK2 Q07912 3/20 0.43
CHEK1 O14757 1/20 0.43
ABL1 P00519 1/20 0.43
LCK P06239 1/20 0.43
ROS1 P08922 1/20 0.43
FGFR1 P11362 1/20 0.43
SRC P12931 1/20 0.43
TYK2 P29597 1/20 0.43
ALK Q9UM73 1/20 0.43
MAP3K7 O43318 1/20 0.43
MAPK1 P28482 1/20 0.43
MAP2K1 Q02750 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22635157 1.00 ULK1 (0.52) ULK1ULK2JAK3JAK1JAK2
SCHEMBL29490507 0.90 JAK3 (0.49) ULK1ULK2JAK3JAK1JAK2
SCHEMBL22635291 0.90 JAK3 (0.49) ULK1ULK2JAK3JAK1JAK2
SCHEMBL22635205 0.90 FLT4 (0.48) JAK3JAK1JAK2TBK1FLT4
SCHEMBL29490427 0.90 FLT4 (0.48) JAK3JAK1JAK2TBK1FLT4
SCHEMBL22635441 0.90 TBK1 (0.46) ULK1ULK2JAK3JAK1JAK2
SCHEMBL29490560 0.90 TBK1 (0.46) ULK1ULK2JAK3JAK1JAK2
SCHEMBL22635138 0.90 TBK1 (0.60) ULK1ULK2JAK3JAK1JAK2
SCHEMBL22635455 0.90 JAK1 (0.51) ULK1ULK2JAK3JAK1JAK2
SCHEMBL29490543 0.90 JAK1 (0.51) ULK1ULK2JAK3JAK1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3966206-B1 HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS LLC (US) 2023-08-09 EP claimed
EP-3966206-A1 HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF Deciphera Pharmaceuticals, LLC (US) 2022-03-16 EP claimed
EP-3966206-A1 HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF Deciphera Pharmaceuticals, LLC (US) 2022-03-16 EP disclosed